Singular Genomics News

Singular Genomics Sys Analyst Ratings

BenzingaJan 23 09:19 ET

Singular Genomics Sys Analyst Ratings

BenzingaJan 22 07:46 ET

Hold Rating on Singular Genomics Systems (OMIC) Amid Q3 Underperformance and Strategy Shift

TipRanksNov 16, 2023 01:55 ET

UBS Adjusts Singular Genomics Systems Price Target to $0.40 From $0.90, Maintains Neutral Rating

MT NewswiresOct 12, 2023 11:28 ET

Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $1

BenzingaAug 10, 2023 09:36 ET

Singular Genomics Sys Analyst Ratings

BenzingaAug 10, 2023 09:34 ET

UBS Adjusts Singular Genomics Systems Price Target to $1.25 From $2.25, Maintains Neutral Rating

MT NewswiresMay 10, 2023 10:11 ET

UBS Adjusts Singular Genomics Systems Price Target to $2.25 From $2.50, Maintains Neutral Rating

MT NewswiresMar 6, 2023 12:31 ET

UBS Adjusts Singular Genomics Systems Price Target to $2.50 From $4.50, Maintains Neutral Rating

MT NewswiresNov 8, 2022 10:24 ET

Singular Genomics Sys Analyst Ratings

Benzinga Analyst RatingsNov 8, 2022 08:29 ET

Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $3

Benzinga Real-time NewsNov 8, 2022 08:28 ET

Singular Genomics Systems (OMIC) Was Downgraded to a Hold Rating at J.P. Morgan

TipRanksSep 7, 2022 08:40 ET

Singular Genomics Systems (OMIC) Was Downgraded to a Hold Rating at J.P. Morgan

TipRanksAug 31, 2022 08:30 ET

Singular Genomics Systems Cut to Neutral From Buy by UBS

Dow JonesAug 17, 2022 06:28 ET

Singular Genomics Systems Price Target Cut to $4.50/Share From $10.00 by UBS

Dow JonesAug 17, 2022 06:28 ET

Singular Genomics Sys Analyst Ratings

Benzinga Analyst RatingsAug 17, 2022 06:21 ET

UBS Downgrades Singular Genomics Sys to Neutral, Lowers Price Target to $4.5

Benzinga Real-time NewsAug 17, 2022 06:20 ET

Singular Genomics Systems (OMIC) Was Downgraded to a Hold Rating at J.P. Morgan

TipRanksAug 16, 2022 08:35 ET

Singular Genomics Systems Price Target Announced at $3.00/Share by B of A Securities

Dow JonesAug 10, 2022 08:10 ET

Singular Genomics Systems Cut to Underperform From Buy by B of A Securities

Dow JonesAug 10, 2022 08:10 ET